Comparison of two laboratory developed PD-L1 assays with clinically approved Ventana SP142 assay and prognostic significance of PD-L1-positivity and immune cell densities in triple-negative breast cancer patients

Comparison of two laboratory developed PD-L1 assays with clinically approved Ventana SP142 assay and prognostic significance of PD-L1-positivity and immune cell densities in triple-negative breast cancer patients

Bibliographic Details
Main Author: Lehto, Niina
Other Authors: Matemaattis-luonnontieteellinen tiedekunta, Faculty of Sciences, Bio- ja ympäristötieteiden laitos, Department of Biological and Environmental Science, Jyväskylän yliopisto, University of Jyväskylä, Solu- ja molekyylibiologia, Cell and molecular biology, 4013
Format: Master's thesis
Language:eng
Published: 2020
Subjects:
rintasyöpä
rinnat
immuunijärjestelmä
immunologia
diagnostiikka
breast cancer
breasts
immune system
immunology
diagnostics
Online Access: https://jyx.jyu.fi/handle/123456789/73209
Description
Description not available.

Similar Items